TMED2_HUMAN - dbPTM
TMED2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TMED2_HUMAN
UniProt AC Q15363
Protein Name Transmembrane emp24 domain-containing protein 2
Gene Name TMED2
Organism Homo sapiens (Human).
Sequence Length 201
Subcellular Localization Cytoplasmic vesicle membrane
Single-pass type I membrane protein . Cytoplasmic vesicle, COPI-coated vesicle membrane
Single-pass type I membrane protein . Golgi apparatus, cis-Golgi network membrane
Single-pass type I membrane protein . Golgi appara
Protein Description Involved in vesicular protein trafficking. Mainly functions in the early secretory pathway but also in post-Golgi membranes. Thought to act as cargo receptor at the lumenal side for incorporation of secretory cargo molecules into transport vesicles and to be involved in vesicle coat formation at the cytoplasmic side. In COPII vesicle-mediated anterograde transport involved in the transport of GPI-anchored proteins and proposed to act together with TMED10 as their cargo receptor; the function specifically implies SEC24C and SEC24D of the COPII vesicle coat and lipid raft-like microdomains of the ER. Recognizes GPI anchors structural remodeled in the ER by PGAP1 and MPPE1. In COPI vesicle-mediated retrograde transport inhibits the GTPase-activating activity of ARFGAP1 towards ARF1 thus preventing immature uncoating and allowing cargo selection to take place. Involved in trafficking of G protein-coupled receptors (GPCRs). Regulates F2RL1, OPRM1 and P2RY4 exocytic trafficking from the Golgi to the plasma membrane thus contributing to receptor resensitization. Facilitates CASR maturation and stabilization in the early secretory pathway and increases CASR plasma membrane targeting. Proposed to be involved in organization of intracellular membranes such as the maintenance of the Golgi apparatus. May also play a role in the biosynthesis of secreted cargo such as eventual processing..
Protein Sequence MVTLAELLVLLAALLATVSGYFVSIDAHAEECFFERVTSGTKMGLIFEVAEGGFLDIDVEITGPDNKGIYKGDRESSGKYTFAAHMDGTYKFCFSNRMSTMTPKIVMFTIDIGEAPKGQDMETEAHQNKLEEMINELAVAMTAVKHEQEYMEVRERIHRAINDNTNSRVVLWSFFEALVLVAMTLGQIYYLKRFFEVRRVV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
71UbiquitinationPDNKGIYKGDRESSG
CCCCCCCCCCCCCCC
53.03-
792-HydroxyisobutyrylationGDRESSGKYTFAAHM
CCCCCCCCEEEEEEC
42.96-
79AcetylationGDRESSGKYTFAAHM
CCCCCCCCEEEEEEC
42.9625038526
99PhosphorylationFCFSNRMSTMTPKIV
EEECCCCCCCCCEEE
16.2826437602
121SulfoxidationEAPKGQDMETEAHQN
CCCCCCCCCCHHHHH
5.4430846556
129UbiquitinationETEAHQNKLEEMINE
CCHHHHHHHHHHHHH
51.18-
142PhosphorylationNELAVAMTAVKHEQE
HHHHHHHHHHHHHHH
20.6820068231
142O-linked_GlycosylationNELAVAMTAVKHEQE
HHHHHHHHHHHHHHH
20.68OGP
150PhosphorylationAVKHEQEYMEVRERI
HHHHHHHHHHHHHHH
9.77-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TMED2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TMED2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TMED2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TMED4_HUMANTMED4physical
22939629
ERGI1_HUMANERGIC1physical
26344197
HNRL1_HUMANHNRNPUL1physical
26344197
DHB12_HUMANHSD17B12physical
26344197
RS10_HUMANRPS10physical
26344197
TM9S4_HUMANTM9SF4physical
26344197
TMEDA_HUMANTMED10physical
26344197
TMED3_HUMANTMED3physical
26344197
TMED4_HUMANTMED4physical
26344197
TMED9_HUMANTMED9physical
26344197
GOGB1_HUMANGOLGB1physical
28514442
TMED4_HUMANTMED4physical
28514442
TMED7_HUMANTMED7physical
28514442
TMED3_HUMANTMED3physical
28514442
DJC30_HUMANDNAJC30physical
28514442
UBP22_HUMANUSP22physical
28514442
FGRL1_HUMANFGFRL1physical
28514442
ATP9A_HUMANATP9Aphysical
28514442
PNPT1_HUMANPNPT1physical
28514442
TMED1_HUMANTMED1physical
28514442
OSBL6_HUMANOSBPL6physical
28514442
AT8B2_HUMANATP8B2physical
28514442
AT12A_HUMANATP12Aphysical
28514442
TMED5_HUMANTMED5physical
28514442

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TMED2_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP